MichaelDFeldmanMDPhD
Pathology • Indianapolis, INAnatomic Pathology, Clinical Pathology, Surgical Pathology
Chair of Pathology Indiana University School of Medicine
Dr. Feldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 W 11th St
Indianapolis, IN 46202Phone+1 317-491-6000Fax+1 317-491-6534
Summary
- Dr. Michael Feldman is Chair of Pathology at Indiana University and is affiliated with multiple hospitals in the area. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 30 years. He specializes in anatomic pathology and surgical pathology and is experienced in immunohistochemistry, health technology/informatics, laboratory informatics, breast pathology, and digital pathology.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1992 - 1998
Rutgers New Jersey Medical SchoolClass of 1992
Certifications & Licensure
IN State Medical License 2023 - 2025
PA State Medical License 1993 - 2024
NJ State Medical License 2021 - 2023- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- 737 citationsTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.Joseph L. Benci, Bihui Xu, Yu Qiu, Tony J. Wu, Hannah Dada
Cell. 2016-12-01 - 289 citationsOrigin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung CancerSunil Singhal, Pratik Bhojnagarwala, Shaun O'Brien, Edmund K. Moon, Alfred L. Garfall
Cancer Cell. 2016-07-11 - 96 citationsPalbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical DevelopmentAmy S. Clark, Thomas B. Karasic, Angela DeMichele, David J. Vaughn, Mark H. O'Hara
JAMA Oncology. 2016-02-01
Journal Articles
- Distinct Microbial Signatures Associated with Different Breast Cancer TypesAngela M. DeMichele, Michael D. Feldman, Frontiers in Neurology
Press Mentions
Attention All Surgical Pathologists: Algorithms for Automated Primary Diagnosis of Digital Pathology Images Likely to Gain Regulatory Clearance in near FutureJune 14th, 2021
Decoding the Microbial Signature of Aggressive Form of Breast CancerOctober 15th, 2015
Finding the Needle in a Microbial HaystackFebruary 12th, 2016
Professional Memberships
- Member
- Fellow
- Fellow
- Member
External Links
- Michael Feldman Dept Websitehttps://ec2-54-173-106-19.compute-1.amazonaws.com/department/people/243/michael-d-feldman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
